Guidance for 2026 revenue was made explicit at $10 million, with commercialization now targeted for late 2026. The previous quarter did not provide specific 2026 revenue guidance.

Peetz announced 2026 net product sales guidance of $630 million to $650 million. He emphasized pipeline progress, noting the approval of CTEXLI for CTX, a tablet formulation of LIVMARLI, and ...

Operator: Good day, and welcome to the Solid Power Fourth Quarter 2025 Earnings Conference Call. [Operator Instructions] ...

The exercised warrants were issued in connection with the Company's February 2024 financing and carried an exercise price of $0.20 per common share. The Company further announces that the remaining $0 ...

Checking up on the claims of water filter makers can be a discomfiting maze. Here's how to verify independent water filter ...

An informational consumer overview of Lottery Defeated software in 2026, analyzing the platform's AI prediction claims, Smart Pick algorithm language, pricing structure, refund policy, and what ...

So you've decided to become a leaker. Be it government corruption, corporate malfeasance, evidence of Russian hacking, or just some garden-variety, messed up shit someone wants to stay under wraps—a ...

On track for INLIGHT clinical data update in 1Q 2026; fat loss similar to GLP-1 observed at three months and expected to continue over time and ...

Oryzon Genomics, S.A. (ISIN Code: ES0167733015, ORY), a clinical-stage biopharmaceutical company and a global leader in epigenetics, today reported financial results for the twelve months ended ...

On track for INLIGHT clinical data update in 1Q 2026; fat loss similar to GLP-1 observed at three months and expected to continue over time and with higher doses of WVE-007 (INHBE GalNAc-siRNA), while ...

Scorpio Gold Corp. (TSXV: SGN) (OTCQB: SRCRF) (FSE: RY9) ("Scorpio Gold", or the "Company") is pleased to announce that, over the ...